Marwick TH .2005 .Diabetic heart disease. Heart, 067231(3) : 296-300.
Li YW,Aronow WS .2011 .Diabetes mellitus and cardiovascular disease. J Clinic Experiment Cardiol, 2 : 2.
.2008 .. Health Information Systems of the Information, : 29-31.
Elwahaab Abd,Rahmy HA,Hagag AF,Fares AA,Fouad HM,SA HM .2019 .Effect of Aerobic exercises on Blood coagulation and Fibrinolysis factors in Elderly Hypertensive patients. J. Adv. Pharm. Edu. Res, 9(1) : 44-8.
Yusransyah ,Halimah E,Suwantika A A .2019 .Utilization and cost minimization study of antihypertensive drugs in primary healthcare center. J. Adv. Pharm. Edu. Res, 9(4) : 83-88.
Alismail AI,Alosaimi WA,Faqihi AY,Al-Sahagi RJ,Alfraiji AF,Aloofy OA,Alhaidar SM,Alfaifi AA,Alrasheed MS,Alkhurayb NT .2020 .Hypertension Diagnosis and Management Approach. Int. J. Pharm. Res. Allied Sci, 9(1) : 84-8.
Almuqati AL,Alluqmani MS,Balhareth SH,Alosaimi MA,Alosaimi MM,Alzughaibi AM,Alshammary AM,Alzamel NA,Alwohaibi NM,Alqurashi AA,Alanazi DF AA .2020 .Evaluation of Role of Family Physicians in Management and Diagnosis of Hypertension in Primary Health Care Centers. Int. J. Pharm. Res. Allied Sci, 9(1) : 105-9.
Mills K.T. ,Bundy J.D.,Kelly T.N. .2016 .Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. , 134 : 441-450.
Matheus AS,Tannus LR,Cobas RA,Palma CC,Negrato CA,Gomes MB .2013 .Impact of diabetes on cardiovascular disease: an update. Int J Hypertens, : 653789.
Fisher M .2003 .Diabetes and atherogenesis. Heart. 2004 Mar, 10(3) : PMC1768108-40.
Keating ST,Plutzky J,El-Osta A .2016 .Epigenetic changes in diabetes and cardiovascular risk. Circ Res, 118 : 1706-1722.
Petrie JR,Guzik TJ,Touyz RM .2017 .Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol, 12(5) : 575-584.
Ali MK,Narayan KM,Tandon N.,Diabetes N. .2010 .& coronary heart disease: current perspectives. Indian J Med Res, 132(5) : 584-597.
Shen Y,Dai Y,Wang XQ,Zhang RY,Lu L,Ding FH,Shen WF . .Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease. 2019 Dec, 1(1) : 160.
Sunkara N .2017 .Published 2017 Feb 15. Cardiovasc Endocrinol, 10(1) : 33-38.
Chiha M,Njeim M,Chedrawy EG .2012 .Diabetes and coronary heart disease: a risk factor for the global epidemic. Int J Hypertens, 10 : .
Lin MJ,Chen CY,Lin HD,Wu HP .2017 .Published 2017 Jan 5. BMC Cardiovasc Disord, 10(1) : 12.
De Rosa S,Arcidiacono B,Chiefari E,Brunetti A,Indolfi C .2018 .Published 2018 Jan 17. Foti DP. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links. Front Endocrinol (Lausanne), 10 : .
de Simone G,Devereux RB,Chinali M,Lee ET,Galloway JM,Barac A,Panza JA,Howard BV .2010 .Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens, 10(2) : 353-360.
.2017 .GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. , 390(10100) : 1345-422.
Forouzanfar MH,Liu P,Roth GA,Ng M,Biryukov S,Marczak L,Alexander L,Estep K,Abate KH,Akinyemiju TF,Ali R .1990 .Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg. 2017 Jan, 10(2) : 165-82.
.2016 .. Global report on diabetes. Geneva:, : .
Care Diabetes .2018 .9. Cardiovascular disease and risk management: standards of medical care in Diabetes-2018. , 41(Suppl 1) : S86-104.
Geiss LS,Herman WM,Smith PJ . .Mortality in non-insulin-dependent diabetes. Diabetes in America. 2nd ed. Bethesda, MD: NIH & NIDDK: National Diabetes Information Clearinghouse; 1995, : 233-55.
Wang MH,Li J,Yeung VS,Zee BC,Yu RH,Ho S,Waye MM .2014 .Four pairs of gene-gene interactions associated with increased risk for type 2 diabetes (CDKN2BAS-KCNJ11), obesity (SLC2A9-IGF2BP2, FTO-APOA5), and hypertension (MC4R-IGF2BP2) in Chinese women. Meta Gene, 2 : 384-391.
Stern M.P.,Haffner S.M.,Hazuda H.P.,Patterson J.K. .1990 .Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. Am J Epidemiol, 131 : 423-433.
Gress TW,Nieto FJ,Shahar E,Wofford MR,Brancati FL .2000 .Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus: Atherosclerosis Risk in Communities Study. N Engl J Med, 342 : 905-912.
Cheung BM . .The hypertension-diabetes continuum. 2010 Apr, 1(4) : 333-9.
.1995 .Diabetes in America. 2nd edition. Bethesda, MD, USA: National Institutes of Health, National Institute of Diabetes and Digestive. , : .
.1993 .Treatment of hypertension in diabetes. Diabetes Care, 16 : 1394-1401.
Keating S,Plutzky J,El-Osta A .2016 .Epigenetic changes in diabetic and cardiovascular risk. Circ Res, 118 : 1706-1722.
Fox CS,Pencina MJ,Wilson PW,Paynter NP,Vasan RS,D'Agostino RB RS .2008 .Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diab Care, 10 : 0025-1584.
Van Hateren KJ,Landman GW,Kleefstra N,Logtenberg SJ,Groenier KH,Kamper AM,Houweling ST,Bilo HJ .2009 .4:e8464. , 0008464 : .
Mohammedi K,Woodward M,Marre M,Colagiuri S,Cooper M,Harrap S,Mancia G,Poulter N,Williams B,Zoungas S .2017 .Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes. Cardiovasc Diabetol, 10 : 95.
Yoo WS,Kim HJ,Kim D,Lee MY,Chung HK . .Early detection of asymptomatic coronary artery disease in patients with type 2 diabetes mellitus. 2009 Sep;24, (3) : 183.
Straka RJ,Liu LZ,Girase PS,DeLorenzo A,Chapman RH .2009 .Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting. Cardiovasc Diabetol, 10 : 1475.
Stamler J,Vaccaro O,Neaton JD,Wentworth D.,Diabetes D. .1993 .other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 16 : 434.
Einarson TR,Acs A,Ludwig C,Panton UH . .Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. 2018 Dec, 1(1) : 83.